Year 2022 in review – Perioperative pain therapy

Česká verzia

Authors: J. Málek
Authors place of work: Klinika anesteziologie a resuscitace 3. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha
Published in the journal: Anest. intenziv. Med., 33, 2022, č. 6, s. 296-301
Category: Review Article

Summary

The article highlights and discusses several current topics that were published in the field of mainly acute pain therapy last year. It summarizes the current publications concerning systemic analgesia, methods of pain therapy and international guidelines concerning pain therapy.

Keywords:

Analgesics – chronic postoperative pain – perioperative analgesia – international guidelines for acute pain therapy

Zdroje

1. Málek J, Ševčík P a kol. Léčba pooperační bolesti. 4. přepracované a doplněné vydání. Praha: Maxdorf; 2021, ISBN 978-80-7345-696-2.

2. Doporučený postup Léčba akutní pooperační bolesti. [Internet]. [cited 2022-11-11]. Available from: https://www.csarim.cz/getmedia/8802cabe‑b620- 4839-9365-518af89e4f4f/DP_CSARIM_ pooperacni‑bolest- 18-4-final‑chir. pdf.aspx

3. Mariano ER, Dickerson DM, Szokol JW, Harned M, Mueller JT, Philip BK, et al. A multisociety organizational consensus process to define guiding principles for acute perioperative pain management. Reg Anesth Pain Med. 2022 Feb;47(2):118-127. doi: 10.1136/rapm-2021-103083.

4. Levy N, Quinlan J, El‑Boghdadly K, Fawcett WJ, Agarwal V, Bastable RB, et al. An international multidisciplinary consensus statement on the prevention of opioid‑related harm in adult surgical patients. Anaesthesia. 2021;76:520-36.

5. Albrecht E, Kehlet H, Raeder J, Joshi GP. Impact of country of origin on procedure‑specific postoperative pain management (PROSPECT) recommendations. Anaesthesia. 2022 Sep;77(9): 1057-1059. doi: 10.1111/anae.15796.

6. National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16 s: Assessment of all chronic pain and management of chronic primary pain. [NICE guideline No. 192], 2021. [Internet]. [cited 2022-11-11]. Available from: https://www.nice.org.uk/ guidance/ng193/.

7. The British Pain Society. Joint statement of clarification on the latest nice chronic pain guidance; regarding patients already on medication. 2021. [Internet]. [cited 2022-11-11]. Available from: https://www.britishpainsociety.org/static/uploads/resources/files/NICE_Chronic_Pain_ Statment_Finalv1.1_22April2021.pdf.

8. Faculty of Pain Medicine. FPM concerns regarding new NICE Chronic Pain Guidelines. 2021. [Internet]. [cited 2022-11-11]. Available from: https://fpm.ac.uk/fpmconcerns‑regarding‑new‑nice‑chronic‑pain‑guidelines.

9. Korwisi B, Barke A, Kharko A, Bruhin C, Locher C, Koechlin H. Not really nice: a commentary on the recent version of NICE guidelines [NG193: chronic pain (primary and secondary) in over 16 s: assessment of all chronic pain and management of chronic primary pain] by the Pain Net. Pain Rep. 2021 Oct 22;6(4):e961. doi: 10.1097/PR9.0000000000000961.

10. Maher DP, Wong CH, Siah KW, Lo AW. Estimates of probabilities of successful development of pain medications: An analysis of pharmaceutical clinical development programs from 2000 to 2020. Anesthesiology. 2022 Aug 1;137(2):243-251. doi: 10.1097/ALN.0000000000004265.

11. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER https). Development of non‑ opioid analgesics for acute pain guidance for industry. 2022 [Internet]. [cited 2022-11-11]. Available from: https://www.fda.gov/media/156063/download.

12. Stewart J. Seglentis FDA approval history 2021. [Internet]. [cited 2022-11-11]. Available from: https://www.drugs.com/history/seglentis.html#.

13. FDA. Tramadol IV: A multidisciplinary review. 2022. [Internet]. [cited 2022-11-11]. Available from: https://www.fda.gov/media/156225/download.

14. Intravenous (IV) tramadol for use in medically supervised health care setting. Avenue Therapeutics Inc. 2022.

15. FDA. Exemption and exclusion from certain requirements of the Drug supply chain security act for the distribution of FDA‑approved naloxone products during the opioid public health emergency. 2022. [Internet]. [cited 2022-11-11]. Available from: https://www.regulations. gov/docket/FDA-2022-D-1847.

16. National Center for Health Statistics. U.S. overdose deaths in 2021 increased half as much as in 2020 – but are still up 15%. [Internet]. [cited 2022-11-11]. Available from: https://www.cdc. gov/nchs/pressroom/nchs_press_releases/2022/202205.htm.

17. Kuehn BM. Growing role of gabapentin in opioid‑related overdoses highlights misuse potential and off‑label prescribing practices. JAMA. 2022 Oct 4;328(13):1283-1285. doi: 10.1001/ jama.2022.13659.

18. Young KD. FDA, DEA pushed to make gabapentin a controlled substance to stop ‚widespread misuse’. Medscape 2022. [Internet]. [cited 2022-11-11]. Available from: https://www. medscape.com/viewarticle/969829.

19. FDA. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)2019. [Internet]. [cited 2022-11-11]. Available from: https://www.fda.gov/drugs/drug‑safety‑and‑availability/ fda‑warns‑about‑serious‑breathing‑problems‑seizure‑and‑nerve‑pain‑medicines‑gabapentin‑neurontin.

20. Slomski A. Perioperative gabapentin linked to harms for older adults. JAMA. 2022 Nov 1;328(17):1677-1678. doi: 10.1001/jama.2022.18442.

21. Park CM, Inouye SK, Marcantonio ER, Metzger E, Bateman BT, Lie JJ, et al. Perioperative gabapentin use and in‑hospital adverse clinical events among older adults after major surgery. JAMA Intern Med. 2022 Nov 1;182(11):1117-1127. doi: 10.1001/jamainternmed.2022.3680.

22. Bongiovanni T, Anderson TS, Marcum ZA. Perioperative gabapentin use in older adults: revisiting multimodal pain management. JAMA Intern Med. 2022;182(11):1127-1128. doi:10.1001/ jamainternmed.2022.3757.

23. Nielsen NI, Kehlet H, Gromov K, Troelsen A, Husted H, Varnum C, Kjærsgaard‑Andersen P, Rasmussen LE, Pleckaitiene L, Foss NB. High‑dose steroids in high pain responders undergoing total knee arthroplasty: a randomised double‑blind trial. Br J Anaesth. 2022;128(1):150-158. doi: 10.1016/j.bja.2021. 10. 001.

24. Mitchell C, Cheuk SJ, O’Donnell CM, Bampoe S, Walker D. What is the impact of dexamethasone on postoperative pain in adults undergoing general anaesthesia for elective abdominal surgery: a systematic review and meta‑analysis. Perioper Med (Lond). 2022;11(1):13. doi: 10.1186/s13741-022-00243-6.

25. Gasbjerg KS, Hägi‑Pedersen D, Lunn TH, Laursen CC, Holmqvist M, Vinstrup LØ et al. Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial. BMJ. 2022 Jan 4;376:e067325. doi: 10.1136/bmj-2021-067325.

26. Køppen KS, Gasbjerg KS, Andersen JH, Hägi‑Pedersen D, Lunn TH, Mathiesen O. Systemic glucocorticoids as an adjunct to treatment of postoperative pain after total hip and knee arthroplasty: A systematic review with meta‑analysis and trial sequential analysis. Eur J Anaesthesiol. 2022 Nov 4. doi: 10.1097/EJA.0000000000001768. Epub ahead of print.

27. Liszka H, Zając M, Gądek A. Pre‑emptive analgesia with methylprednisolone and gabapentin in total knee arthroplasty in the elderly. Sci Rep. 2022;12(1):2320. doi: 10.1038/s41598-022- 05423-4. PMID: 35149701; PMCID: PMC8837623.

28. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara Det al. Cannabis‑based products for chronic pain : A systematic review. Ann Intern Med. 2022;175(8):1143-1153. doi: 10.7326/M21-4520.

29. Lin AL, Nah G, Tang JJ, Vittinghoff E, Dewland TA, Marcus GM. Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation. Eur Heart J. 2022 Oct 18:ehac558. doi: 10.1093/eurheartj/ehac558.

30. Arriaga AF, Bader AM. Severe pain after hip fracture repair in older adults: Challenging a dominant narrative. Ann Intern Med. 2022 Jul;175(7):1039-1040. doi: 10.7326/M22-1391.

31. Neuman MD, Feng R, Carson JL, Gaskins LJ, Dillane D, Sessler DI et al; REGAIN Investigators. Spinal anesthesia or general anesthesia for hip surgery in older adults. N Engl J Med. 2021;385:2025-2035.doi:10.1056/NEJMoa2113514.

32. Neuman MD, Feng R, Ellenberg SS, Sieber F, Sessler DI, Magaziner J, et al; REGAIN (Regional versus General Anesthesia for Promoting Independence after Hip Fracture) Investigators*. Pain, analgesic use, and patient satisfaction with spinal versus general anesthesia for hip fracture surgery : A randomized clinical trial. Ann Intern Med. 2022;175(7):952-960. doi: 10.7326/M22-0320.

33. Li T, Li J, Yuan L, Wu J, Jiang C, Daniels J, et al; RAGA Study Investigators. Effect of regional vs general anesthesia on incidence of postoperative delirium in older patients undergoing hip fracture surgery: The RAGA randomized trial. JAMA. 2022 Jan 4;327(1):50-58. doi: 10.1001/ jama.2021.22647.

34. Kendall MC, Cohen AD, Principe‑Marrero S, Sidhom P, Apruzzese P, De Oliveira G. Spinal versus general anesthesia for patients undergoing outpatient total knee arthroplasty: a national propensity matched analysis of early postoperative outcomes. BMC Anesthesiol. 2021 Sep 15;21(1):226. doi: 10.1186/s12871-021-01442-2.

35. Exsteen OW, Svendsen CN, Rothe C, Lange KHW, Lundstrøm LH. Ultrasound‑guided peripheral nerve blocks for preoperative pain management in hip fractures: a systematic review. BMC Anesthesiol. 2022 Jun 21;22(1):192. doi: 10.1186/s12871-022-01720-7.

36. Lavand’homme PM, Kehlet H, Rawal N, Joshi GP; PROSPECT working group of the European Society of Regional Anaesthesia and Pain Therapy (ESRA). Pain management after total knee arthroplasty: PROcedure SPEcific Postoperative Pain ManagemenT recommendations. Eur J Anaesthesiol. 2022;39(9):743-757. doi: 10.1097/EJA.0000000000001691.

37. Waelkens P, Alsabbagh E, Sauter A, Joshi GP, Beloeil H; PROSPECT Working group** of the European Society of Regional Anaesthesia and Pain therapy (ESRA). Pain management after complex spine surgery: A systematic review and procedure‑specific postoperative pain management recommendations. Eur J Anaesthesiol. 2021;38(9):985-994. doi: 10.1097/ EJA.0000000000001448.

38. Higgins O, Rule S, Cleary J. Analgesics of the Future: The potential of vocacapsaicin injections for knee pain. Pract Pain Manag. 2021;21(2). [Internet]. [cited 2022-11-11]. Available from: https://www.practicalpainmanagement.com/treatments/pharmacological/non‑opioids/ analgesics‑future‑novel‑capsaicin‑formulation‑cntx- 4975

. 39. Anger M, Valovska T, Beloeil H, Lirk P, Joshi GP, Van de Velde M, et al; PROSPECT Working Group* and the European Society of Regional Anaesthesia and Pain Therapy. PROSPECT guideline for total hip arthroplasty: a systematic review and procedure‑specific postoperative pain management recommendations. Anaesthesia. 2021 Aug;76(8):1082-1097. doi: 10.1111/anae.15498.

40. Rivas E, Cohen B, Pu X, Xiang L, Saasouh W, Mao G, et al. Pain and opioid consumption and mobilization after surgery: Post hoc analysis of two randomized trials. Anesthesiology. 2022;136(1):115-126. doi: 10.1097/ALN.0000000000004037.

41. Pirie K, Doane MA, Riedel B, Myles PS. Analgesia for major laparoscopic abdominal surgery: a randomised feasibility trial using intrathecal morphine. Anaesthesia 2022. Epub 17 January. [Internet]. [cited 2022-11-11]. Available from: https://doi.org/10.1111/anae.15651.

42. Hasselager RP, Hallas J, Gögenur I. Epidural analgesia and postoperative complications in colorectal cancer surgery. An observational registry‑based study. Acta Anaesthesiol Scand. 2022;66(7):869-879. doi: 10.1111/aas.14101.

43. Acute pain management. ICU Management & Practice. 2022;22(3) [Internet]. [cited 2022- 11-11]. Available from: https://healthmanagement.org/c/icu/issue/volume-22-issue-3-2022.

44. Shellito AD, Dworsky JQ, Kirkland PJ, Rosenthal RA, Sarkisian CA, Ko CY, et al. Perioperative pain management issues unique to older adults undergoing surgery: A narrative review. Ann Surg Open. 2021 Sep;2(3):e072.

45. Wilson SH, Wilson PR, Bridges KH, Bell LH, Clark CA. Nonopioid analgesics for the perioperative geriatric patient: A narrative review. Anesth Analg. 2022 Aug 1;135(2):290-306. doi: 10.1213/ ANE.0000000000005944.

46. Dias J, Zaveri S, Divino C. Postoperative opioid prescribing patterns in the geriatric patient population. Am J Surg. 2022 Jul;224(1 Pt B):418-422. doi: 10.1016/j.amjsurg.2021. 12. 029.

47. Raeder J. Pain treatment and prophylaxis on pain. Curr Opin Anaesthesiol. 2022;35(6): 684-690. doi: 10.1097/ACO.0000000000001190.

48. Geradon P, Lavand’homme P. Use of regional analgesia to prevent the conversion from acute to chronic pain. Curr Opin Anaesthesiol. 2022 Oct 1;35(5):641-646. doi: 10.1097/ ACO.0000000000001175.

49. Lukas A, Buhre W. Individualized multidisciplinary analgesia to prevent persistent postsurgical pain. Curr Opin Anaesthesiol. 2022 Jun 1;35(3):380-384. doi: 10.1097/ACO.0000000000001140.

50. Polanco‑García M, Granero R, Gallart L, García‑Lopez J, Montes A. Finding the vulnerable postoperative population: A two‑step cluster analysis of the PAIN‑OUT registry. Eur J Pain. 2022 Sep;26(8):1732-1745. doi: 10.1002/ejp.1997.

51. Latijnhouwers DAJM, Martini CH, Nelissen RGHH, Verdegaal SHM, Vliet Vlieland TPM, Gademan MGJ; Longitudinal Leiden Orthopaedics Outcomes of Osteoarthritis Study (LOAS) Group. Acute pain after total hip and knee arthroplasty does not affect chronic pain during the first postoperative year: observational cohort study of 389 patients. Rheumatol Int. 2022 Apr;42(4):689-698. doi: 10.1007/s00296-022-05094-4.

52. Málek J, Kurzová A, Ambruš M, Vedral T, Lysý M, Príkazský V. Chronická postmastektomická bolest. Čas Lék Čes. 2006;145:209-212.

53. Willingham MD, Vila MR, Ben Abdallah A, Avidan MS, Haroutounian S. Factors contributing to lingering pain after surgery: The role of patient expectations. Anesthesiology. 2021;134(6): 915-924. doi: 10.1097/ALN.0000000000003754.

54. Sampaio‑Cunha TJ, Martins I. Knowing the enemy is halfway towards victory: A scoping review on opioid‑induced hyperalgesia. J. Clin. Med. 2022;11:6161. https://doi.org/10.3390/jcm11206161

55. Palmer CB, Meyrath M, Canals M, Kostenis E, Chevigné A, Szpakowska M. Atypical opioid receptors: unconventional biology and therapeutic opportunities. Pharmacol Ther. 2022;233:108014. doi: 10.1016/j.pharmthera.2021.108014.

56. Szpakowska M, Decker AM, Meyrath M, Palmer CB, Blough BE, Namjoshi OA, et al. The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7. Signal Transduct Target Ther. 2021;6(1):209. doi: 10.1038/s41392-021-00548-w.

57. Conolidine. Wikipedia. [Internet]. [cited 2022-11-11]. Available from: https://en.wikipedia. org/wiki/Conolidine.

58. Parisien M, Lima LV, Dagostino C, El‑Hachem N, Drury GL, Grant AV, et al. Acute inflammatory response via neutrophil activation protects against the development of chronic pain. Sci Transl Med. 2022 May 11;14(644):eabj9954. doi: 10.1126/scitranslmed.abj9954.

59. Oransky I, Fremes SE, Kurlansky P, Gaudino M. Retractions in medicine: the tip of the iceberg. Eur Heart J. 2021;42(41):4205-4206. doi: 10.1093/eurheartj/ehab398.